Science Explorer Back to mapMap
Discussion
Company · Seongnam-si · South Korea

NutraPharm Tech (South Korea)

nutrapharm.co.kr/enROR OpenAlex
Research works
7
▼ 58% vs 2018-21
Citations
204
27.8 per fractional work
Top-10% rate
4.5%
all institutions 10.0%
Open access
78%
world 40%
NutraPharm Tech (South Korea)

Not ranked overall: NutraPharm Tech (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NutraPharm Tech (South Korea) work in?

In all years, 55% of research at NutraPharm Tech (South Korea) is in Life Sciences, 44% in Health Sciences. Its largest fields are Medicine (41%), Biochemistry, Genetics and Molecular Biology (25%), Pharmacology, Toxicology and Pharmaceutics (17%). It does 1.7× the world's share of Life Sciences.

Life Sciences: 4 fractional works · 55.3% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 25.0% of its workMolecular Biology: 1 fractional works · 13.6% of its workCancer Research: 0 fractional works · 6.8% of its workBiochemistry: 0 fractional works · 2.3% of its workBiotechnology: 0 fractional works · 2.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 17.5% of its workPharmacology: 1 fractional works · 10.6% of its workPharmaceutical Science: 0 fractional works · 6.8% of its workAgricultural and Biological Sciences: 1 fractional works · 9.8% of its workPlant Science: 1 fractional works · 8.3% of its workFood Science: 0 fractional works · 1.5% of its workNeuroscience: 0 fractional works · 3.0% of its workBiological Psychiatry: 0 fractional works · 1.5% of its workNeurology: 0 fractional works · 1.5% of its workHealth Sciences: 3 fractional works · 43.7% of its workMedicine: 3 fractional works · 41.3% of its workPharmacology: 1 fractional works · 14.1% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 6.8% of its workRheumatology: 0 fractional works · 4.5% of its workComplementary and alternative medicine: 0 fractional works · 3.4% of its workSurgery: 0 fractional works · 2.6% of its workOncology: 0 fractional works · 2.3% of its workPhysiology: 0 fractional works · 2.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.5% of its workEpidemiology: 0 fractional works · 1.5% of its workBiochemistry: 0 fractional works · 1.1% of its workHepatology: 0 fractional works · 1.1% of its workNursing: 0 fractional works · 2.3% of its workNutrition and Dietetics: 0 fractional works · 2.3% of its workSocial Sciences: 0 fractional works · 1.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 1.1% of its workALL ITS WORKNutraPharm Tech(South Korea)7fractional works, all years
Life Sciences55%Health Sciences44%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology225.0%
    2. Pharmacology, Toxicology and Pharmaceutics117.5%
    3. Agricultural and Biological Sciences19.8%
    4. Neuroscience03.0%
    1. Medicine341.3%
    2. Nursing02.3%
    1. Economics, Econometrics and Finance01.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at NutraPharm Tech (South Korea)?

Ranked on the quality score, Dong‐Ryung Lee and Bong‐Keun Choi lead among researchers whose main affiliation is NutraPharm Tech (South Korea).

  1. 1 Dong‐Ryung Lee South Korea · #4,286,338 worldwide 542 citations · 25 works
  2. 2 Bong‐Keun Choi South Korea · #5,294,710 worldwide 1.2k citations · 59 works
All ranked researchers at NutraPharm Tech (South Korea)

What are the most cited papers from NutraPharm Tech (South Korea)?

The most cited paper from NutraPharm Tech (South Korea) is "Green coffee bean extract improves obesity by decreasing body fat in high-fat diet-induced obese mice" (Bong‐Keun Choi, Sung Bum Park, Dong‐Ryung Lee et al., 2016), with 134 citations. Next come "A polymethoxy flavonoids-rich Citrus aurantium extract ameliorates ethanol-induced liver injury through modulation of AMPK and Nrf2-related signals in a binge drinking mouse model" (56) and "Hepatoprotective effects of polymethoxyflavones against acute and chronic carbon tetrachloride intoxication" (38).

Most cited papers
#PaperReleasedCitations
1 Green coffee bean extract improves obesity by decreasing body fat in high-fat diet-induced obese mice Bong‐Keun Choi, Sung Bum Park, Dong‐Ryung Lee et al. · Asian Pacific Journal of Tropical Medicine Open access 30 May 2016 134
2 A polymethoxy flavonoids-rich Citrus aurantium extract ameliorates ethanol-induced liver injury through modulation of AMPK and Nrf2-related signals in a binge drinking mouse model Bong‐Keun Choi, Tae‐Won Kim, Dong‐Ryung Lee et al. · Phytotherapy Research 14 Jul 2015 56
3 Hepatoprotective effects of polymethoxyflavones against acute and chronic carbon tetrachloride intoxication Tae‐Won Kim, Dong‐Ryung Lee, Bong‐Keun Choi et al. · Food and Chemical Toxicology 12 Mar 2016 38
4 Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice Hyoung‐Yun Han, Sung‐Kwon Lee, Bong‐Keun Choi et al. · Biological and Pharmaceutical Bulletin Open access 31 Jan 2019 35
5 Effect of Fermentation on the Antioxidant Activity of Rice Bran by Monascus pilosus KCCM60084 Jinhua Cheng, Bong‐Keun Choi, Seung Hwan Yang et al. · Journal of Applied Biological Chemistry Open access 27 Mar 2016 35
All 17 most cited papers, with filters and sorting

Which research topics does NutraPharm Tech (South Korea) publish most on?

By volume in 2022-now: Phytochemistry and Biological Activities, Microbial Metabolites in Food Biotechnology, Natural product bioactivities and synthesis and Cancer, Lipids, and Metabolism.

Phytochemistry and Biolo…0Phytochemistry and Biological Activities: 0 fractional worksMicrobial Metabolites in…0Microbial Metabolites in Food Biotechnology: 0 fractional worksNatural product bioactiv…0Natural product bioactivities and synthesis: 0 fractional worksCancer, Lipids, and Meta…0Cancer, Lipids, and Metabolism: 0 fractional worksCarcinogens and Genotoxicity Assessment: 0 fractional worksAntibiotics Pharmacokinetics and Efficacy: 0 fractional worksPesticide Residue Analys…0Pesticide Residue Analysis and Safety: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksAtrial Fibrillation Management and Outcomes: 0 fractional worksPhytochemicals and Antio…0Phytochemicals and Antioxidant Activities: 0 fractional works
Plant ScienceNutrition and DieteticsMolecular BiologyCancer Research5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Phytochemistry and Biological Activities Plant Science 0 works
  2. 2 Microbial Metabolites in Food Biotechnology Nutrition and Dietetics 0 works
  3. 3 Natural product bioactivities and synthesis Molecular Biology 0 works
  4. 4 Cancer, Lipids, and Metabolism Cancer Research 0 works
  5. 5 Carcinogens and Genotoxicity Assessment Cancer Research 0 works
  6. 6 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  7. 7 Pesticide Residue Analysis and Safety Food Science 0 works
  8. 8 Lipoproteins and Cardiovascular Health Surgery 0 works
  9. 9 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  10. 10 Phytochemicals and Antioxidant Activities Biochemistry 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.4%not open21.6%

World: 40% of research is openly available.

How has NutraPharm Tech (South Korea)'s research output changed?

Output in 2022-2025 was 58% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NutraPharm Tech (South Korea). Posts are plain text and can be reported.